RxDoctor Payments Data

Mohammad Seyyedi, MD

Otology & Neurotology · Atlanta, GANPI 1487041653

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,141 of the $3,126 with a category attached, or 68.5%. 19 manufacturers reported payments, led by Acclarent, Inc at 37.4% of the total.

$3,126in general payments, 2019–2025

Across 61 payments — averaging $51.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$1K
  • Sanofi$275
  • Stryker$257
  • Integra Lifesciences Corporation$247
  • Medtronic$188
  • Regeneron Healthcare Solutions, Inc.$176
  • plus $814 from 13 others

What the payments were for

  • Travel & lodging$98131%
  • Food & beverage$2,14169%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$70,439
Medicare patients
201
Services billed
1,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone Sodium Phosphate35$1,394
Azelastine-FluticasoneAzelastine/Fluticasone12$1,178
Ipratropium Bromide36$994
Ciprofloxacin Hcl40$662
Nortriptyline Hcl46$661
Azelastine Hcl19$482
Gabapentin17$439
Cefdinir14$266
Fluticasone Propionate16$181
Pantoprazole Sodium11$175
Ofloxacin13$146
Triamcinolone Acetonide14$76
Methylprednisolone11$40
Prednisone11$11

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →